Sanguine Media Ltd

Sanguine Media Ltd has filed its Annual Report for the Financial Year 2025-2026, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report has been sent to shareholders and uploaded to the company's website. The 31st Annual General Meeting (AGM) is scheduled for September 30, 2026, to adopt the audited financial statements for FY 2025-26 and re-appoint Mr. Sanjay Sunderlal Meena as a Director. The report includes details on the Board of Directors, Auditors, and various sections of the annual report such as the Director's Report, Management Discussion and Analysis, and Auditors' Report.

Sanguine Media Ltd has issued a notice for its 31st Annual General Meeting (AGM) scheduled for Wednesday, September 30, 2026, at 12:30 PM IST. The meeting will be held at the company's registered office in Chennai. Key agenda items include the adoption of the audited financial statements for the fiscal year ended March 31, 2026, and the re-appointment of Mr. Sanjay Sunderlal Meena as a Director who retires by rotation. The notice also details the composition of the Board of Directors, secretarial and statutory auditors, and registrars and share transfer agents.

Sanguine Media Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The company reported a marginal profit before tax of ₹0.06 crore for the quarter, a significant improvement from a loss of ₹0.70 crore in the previous quarter (March 31, 2026). Total income for the quarter stood at ₹1.66 crore. The results were reviewed by the Audit Committee and approved by the Board of Directors. The company operates within a single business segment, thus no segment information is disclosed. The financial results have undergone a limited review by the statutory auditors.

Sanguine Media Ltd announced its un-audited financial results for the quarter ended June 30, 2026. The Board of Directors approved the results along with the Statutory Auditors' Limited Review Report. The company's business activity falls within a single primary business segment, hence no separate segment information is disclosed. The results were prepared in accordance with Indian Accounting Standards.

Sanguine Media Ltd has announced that its Board of Directors will convene on August 11, 2026. The primary agenda item for this meeting is to consider and approve the unaudited financial results for the first quarter ended June 30, 2026. The company will also present the Auditor's Limited Review Report for the same period. The meeting will be held at the company's registered office, and other business may be discussed with the Chairman's permission.

Sanguine Media Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from July 1, 2026, and will remain in effect until 48 hours after the declaration of its Unaudited Financial Results for the Quarter ended June 30, 2026. The decision aligns with SEBI regulations concerning insider trading. Promoters, Directors, KMPs, Designated Persons, Connected Persons, and their immediate relatives are prohibited from trading during this period. The exact date of the Board Meeting to approve the financial results will be announced later.

Sanguine Media Ltd has informed the stock exchange that its Statement of Deviation or Variation for proceeds of public issue/rights issue/preferential issue, etc., under Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, is not applicable for the quarter and year ended March 31, 2026. This is because the company had no public issue, rights issue, or preferential issue during the said period. The company is adhering to SEBI circulars regarding such disclosures.

Sanguine Media Ltd's Board of Directors has approved the standalone audited financial results for the quarter and financial year ended March 31, 2026. The results, including the Statement of Profit & Loss, Statement of Assets & Liabilities, and Statement of Cash Flow, were audited by K. S. Subrahmanyam & Co. The auditors issued an unmodified opinion. The company reported a net loss of ₹0.70 crore for the quarter ended March 31, 2026, compared to a profit of ₹0.04 crore in the preceding quarter and a loss of ₹2.90 crore in the corresponding quarter of the previous year. For the full financial year, the company reported a net loss of ₹15.98 crore.

Sanguine Media Ltd announced its audited standalone financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the financial statements, including the Statement of Profit & Loss, Statement of Assets & Liabilities, and Statement of Cash Flow. The results were reviewed by the Audit Committee and audited by K. S. Subrahmanyam & Co., who issued an unmodified opinion. The company reported a net loss of ₹0.70 crore for the quarter and ₹15.98 crore for the year ended March 31, 2026. No related party transactions were reported for the financial year.

Sanguine Media Ltd has informed the BSE that the Board of Directors meeting, initially convened on May 29 and reconvened on May 30, 2026, has been adjourned and will reconvene on June 9, 2026. The purpose of the meeting is to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. The outcome of the adjourned meeting will be submitted to the Stock Exchange upon conclusion.